- call +1-201-465-4211
- email sales@mrinsights.biz
Lungs in Vitro is applied for Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, and Regenerative Medicine. It include four types that are 2D Cell Models, 3D Cell Models, Commercial 3D Cell Models, and Inhouse 3D Cell Models
Scope of the Report:
The global Lungs in Vitro market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Lungs in Vitro.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Lungs in Vitro market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Lungs in Vitro market by product type and applications/end industries.
Market Segment by Companies, this report covers
ATCC
Lonza
Epithelix
Mattek
Emulate
Mimetas
Tissuse
Insphero
Cn Bio
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
2D Cell Models
3D Cell Models
Commercial 3D Cell Models
Inhouse 3D Cell Models
Market Segment by Applications, can be divided into
Drug Screening
Toxicology
3D Model Development
Basic Research
Physiologic Research
Stem Cell Research
Regenerative Medicine
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Lungs in Vitro Market Overview
1.1 Product Overview and Scope of Lungs in Vitro
1.2 Classification of Lungs in Vitro by Types
1.2.1 Global Lungs in Vitro Revenue Comparison by Types (2017-2023)
1.2.2 Global Lungs in Vitro Revenue Market Share by Types in 2017
1.2.3 2D Cell Models
1.2.4 3D Cell Models
1.2.5 Commercial 3D Cell Models
1.2.6 Inhouse 3D Cell Models
1.3 Global Lungs in Vitro Market by Application
1.3.1 Global Lungs in Vitro Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Drug Screening
1.3.3 Toxicology
1.3.4 3D Model Development
1.3.5 Basic Research
1.3.6 Physiologic Research
1.3.7 Stem Cell Research
1.3.8 Regenerative Medicine
1.4 Global Lungs in Vitro Market by Regions
1.4.1 Global Lungs in Vitro Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Lungs in Vitro Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Lungs in Vitro Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Lungs in Vitro Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Lungs in Vitro Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Lungs in Vitro Status and Prospect (2013-2023)
1.5 Global Market Size of Lungs in Vitro (2013-2023)
2 Manufacturers Profiles
2.1 ATCC
2.1.1 Business Overview
2.1.2 Lungs in Vitro Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 ATCC Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
2.2 Lonza
2.2.1 Business Overview
2.2.2 Lungs in Vitro Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Lonza Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
2.3 Epithelix
2.3.1 Business Overview
2.3.2 Lungs in Vitro Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Epithelix Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
2.4 Mattek
2.4.1 Business Overview
2.4.2 Lungs in Vitro Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Mattek Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
2.5 Emulate
2.5.1 Business Overview
2.5.2 Lungs in Vitro Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Emulate Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mimetas
2.6.1 Business Overview
2.6.2 Lungs in Vitro Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mimetas Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
2.7 Tissuse
2.7.1 Business Overview
2.7.2 Lungs in Vitro Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Tissuse Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
2.8 Insphero
2.8.1 Business Overview
2.8.2 Lungs in Vitro Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Insphero Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cn Bio
2.9.1 Business Overview
2.9.2 Lungs in Vitro Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Cn Bio Lungs in Vitro Revenue, Gross Margin and Market Share (2016-2017)
3 Global Lungs in Vitro Market Competition, by Players
3.1 Global Lungs in Vitro Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Lungs in Vitro Players Market Share
3.2.2 Top 10 Lungs in Vitro Players Market Share
3.3 Market Competition Trend
4 Global Lungs in Vitro Market Size by Regions
4.1 Global Lungs in Vitro Revenue and Market Share by Regions
4.2 North America Lungs in Vitro Revenue and Growth Rate (2013-2018)
4.3 Europe Lungs in Vitro Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Lungs in Vitro Revenue and Growth Rate (2013-2018)
4.5 South America Lungs in Vitro Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Lungs in Vitro Revenue and Growth Rate (2013-2018)
5 North America Lungs in Vitro Revenue by Countries
5.1 North America Lungs in Vitro Revenue by Countries (2013-2018)
5.2 USA Lungs in Vitro Revenue and Growth Rate (2013-2018)
5.3 Canada Lungs in Vitro Revenue and Growth Rate (2013-2018)
5.4 Mexico Lungs in Vitro Revenue and Growth Rate (2013-2018)
6 Europe Lungs in Vitro Revenue by Countries
6.1 Europe Lungs in Vitro Revenue by Countries (2013-2018)
6.2 Germany Lungs in Vitro Revenue and Growth Rate (2013-2018)
6.3 UK Lungs in Vitro Revenue and Growth Rate (2013-2018)
6.4 France Lungs in Vitro Revenue and Growth Rate (2013-2018)
6.5 Russia Lungs in Vitro Revenue and Growth Rate (2013-2018)
6.6 Italy Lungs in Vitro Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Lungs in Vitro Revenue by Countries
7.1 Asia-Pacific Lungs in Vitro Revenue by Countries (2013-2018)
7.2 China Lungs in Vitro Revenue and Growth Rate (2013-2018)
7.3 Japan Lungs in Vitro Revenue and Growth Rate (2013-2018)
7.4 Korea Lungs in Vitro Revenue and Growth Rate (2013-2018)
7.5 India Lungs in Vitro Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Lungs in Vitro Revenue and Growth Rate (2013-2018)
8 South America Lungs in Vitro Revenue by Countries
8.1 South America Lungs in Vitro Revenue by Countries (2013-2018)
8.2 Brazil Lungs in Vitro Revenue and Growth Rate (2013-2018)
8.3 Argentina Lungs in Vitro Revenue and Growth Rate (2013-2018)
8.4 Colombia Lungs in Vitro Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Lungs in Vitro by Countries
9.1 Middle East and Africa Lungs in Vitro Revenue by Countries (2013-2018)
9.2 Saudi Arabia Lungs in Vitro Revenue and Growth Rate (2013-2018)
9.3 UAE Lungs in Vitro Revenue and Growth Rate (2013-2018)
9.4 Egypt Lungs in Vitro Revenue and Growth Rate (2013-2018)
9.5 Nigeria Lungs in Vitro Revenue and Growth Rate (2013-2018)
9.6 South Africa Lungs in Vitro Revenue and Growth Rate (2013-2018)
10 Global Lungs in Vitro Market Segment by Type
10.1 Global Lungs in Vitro Revenue and Market Share by Type (2013-2018)
10.2 Global Lungs in Vitro Market Forecast by Type (2018-2023)
10.3 2D Cell Models Revenue Growth Rate (2013-2023)
10.4 3D Cell Models Revenue Growth Rate (2013-2023)
10.5 Commercial 3D Cell Models Revenue Growth Rate (2013-2023)
10.6 Inhouse 3D Cell Models Revenue Growth Rate (2013-2023)
11 Global Lungs in Vitro Market Segment by Application
11.1 Global Lungs in Vitro Revenue Market Share by Application (2013-2018)
11.2 Lungs in Vitro Market Forecast by Application (2018-2023)
11.3 Drug Screening Revenue Growth (2013-2018)
11.4 Toxicology Revenue Growth (2013-2018)
11.5 3D Model Development Revenue Growth (2013-2018)
11.6 Basic Research Revenue Growth (2013-2018)
11.7 Physiologic Research Revenue Growth (2013-2018)
11.8 Stem Cell Research Revenue Growth (2013-2018)
11.9 Regenerative Medicine Revenue Growth (2013-2018)
12 Global Lungs in Vitro Market Size Forecast (2018-2023)
12.1 Global Lungs in Vitro Market Size Forecast (2018-2023)
12.2 Global Lungs in Vitro Market Forecast by Regions (2018-2023)
12.3 North America Lungs in Vitro Revenue Market Forecast (2018-2023)
12.4 Europe Lungs in Vitro Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Lungs in Vitro Revenue Market Forecast (2018-2023)
12.6 South America Lungs in Vitro Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Lungs in Vitro Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Lungs in Vitro Picture
Table Product Specifications of Lungs in Vitro
Table Global Lungs in Vitro and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
